Prenetics Global Limited Dossier
Qualitative Analysis
Business overview
Prenetics Global Ltd (NASDAQ: PRE) is a leading consumer health sciences company that is redefining the future of health and longevity. The company's flagship consumer brand is IM8, a premium health and longevity supplement brand co-founded with David Beckham and championed by tennis star Aryna Sabalenka. IM8 has emerged as one of the fastest-growing supplement brands globally, reaching $100 million in annual recurring revenue within just 11 months of its launch. In addition to IM8, Prenetics operates CircleDNA, a direct-to-consumer genetic testing brand utilizing next-generation sequencing (NGS) technology to provide comprehensive health, wellness, and disease predisposition insights. The company has also established a Bitcoin treasury strategy, holding digital assets as a long-term reserve.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Pivoting the company's core business model to focus entirely on IM8, its premium health and longevity brand, while divesting non-core assets and digital holdings to redeploy capital into high-growth consumer health and prevention segments.
Expected impact: Establishes Prenetics as a pure-play leader in consumer health and nutrition, driving rapid ARR growth and improving long-term operating leverage.
Building global brand reach and consumer trust through high-profile, equity-aligned partnerships with prominent figures such as David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, and Jay Shetty.
Expected impact: Drives global brand awareness, customer acquisition, and subscription retention across more than 43 countries.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Prenetics completed the sale of its 35% equity stake in the early cancer detection joint venture, Insighta, to Tencent for $70 million in cash, allowing the company to streamline operations and focus resources on IM8.
Terms: $70 million total cash consideration ($69 million received on February 13, 2026, and $1 million held in escrow).
IM8 became the exclusive Official Health Supplements Partner of the Major League Soccer club. The partnership includes name, image, and likeness (NIL) rights to a minimum of four players (including Lionel Messi) and marks the first time Inter Miami CF has taken an equity stake in a brand partner.
Terms: Includes an equity stake in Prenetics granted to Inter Miami CF.
Award-winning podcast host and author Jay Shetty joined as Global Ambassador of IM8 to collaborate with the Scientific Advisory Board on consumer education in foundational nutrition, sleep, and longevity.
Terms: Shetty became a shareholder in Prenetics as part of the agreement.